Machine Learning-Based Risk Prediction for Coronary Heart Disease Complicated by Hyperhomocysteinemia: Retrospective
Ming-Yuan Du1,2,3, Meng-Ke Lyu3, Hai-Long Liu1,2,3
1Heart Center, The First Affiliated Hospital of Henan University of Chinese Medicine, National Regional (TCM) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, China.
Background:
Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for coronary heart disease (CHD), yet accurately predicting CHD risk in patients with HHcy remains a challenge. This study aimed to develop and validate multiple machine learning models for predicting CHD risk in patients with HHcy and elucidate key predictors using Shapley Additive Explanation (SHAP) algorithms.
Objective:
This study aims to develop and validate machine learning models for predicting the risk of coronary heart disease in individuals with normal homocysteine levels, aiming to improve early risk stratification and clinical decision-making.
Methods:
This single-center retrospective study collected data from patients who were diagnosed with HHcy through electronic medical records, which were randomly divided into training (n=364, 70%), validation (n=78, 15%), and test (n=78, 15%) sets. Seven machine learning models were constructed, including logistic regression, k-nearest neighbor, decision tree, random forest, extreme gradient boost, light gradient boosting machine (LightGBM), and stacking. Six core variables (age, weight, hypertension, continuous drinking history, activated partial thromboplastin time, and carotid plaque) were utilized as inputs, with performance evaluation metrics encompassing area under the receiver operating characteristic curve, accuracy, F1-score, calibration curve, Brier score, and decision curve analysis. Additionally, SHAP interpretation was conducted on the optimal LightGBM model.
Results:
The LightGBM model exhibited superior performance in the test set (area under the receiver operating characteristic curve=0.807, F1-score=0.606), demonstrated good calibration (Brier score=0.2415), and yielded high clinical net benefit. SHAP analysis revealed age and activated partial thromboplastin time as the most influential predictors, followed by hypertension, weight, carotid plaque, and continuous drinking history. The correlation heat map illustrated low collinearity among variables, ensuring model stability.
Conclusions:
The LightGBM model demonstrated high accuracy and interpretability in forecasting CHD risk among patients with HHcy. The integration of machine learning and interpretable artificial intelligence methods holds promise for delivering personalized early risk assessment and intervention strategies in clinical settings.
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
